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Abstract
Background: Treatment of traumatised refugees is one of the fields within psychiatry, which has received little
scientific attention. Evidence based treatment and knowledge on the efficiency of the treatment for this complex
patient group is therefore scarce. This leads to uncertainty as to which treatment should be offered and potentially
lowers the quality of life for the patients.
Chronic pain is very common among traumatised refugees and it is believed to maintain the mental symptoms of
trauma. Hence, treating chronic pain is believed to be of high clinical value for this patient group.
In clinical studies, physical activity has shown a positive effect on psychiatric illnesses such as depression and
anxiety and for patients with chronic pain. However, scientific knowledge about physical activity as part of the
treatment for traumatised refugees is very limited and no guidelines exist on this topic.
Methods/design: This study will include approximately 310 patients, randomised into three groups. All three
groups receive psychiatric treatment as usual for the duration of 6–7 months, consisting of consultations with a
medical doctor including pharmacological treatment and manual-based Cognitive Behavioural Therapy. The first
group only receives treatment as usual while the second and the third groups receive either Basic-Body Awareness
Therapy or mixed physical activity as add-on treatments. Each physical activity is provided for an individual 1-hour
consultation per week, for the duration of 20 weeks. The study is being conducted at the Competence Centre for
Transcultural Psychiatry, Mental Health Centre Ballerup in the Capital Region of Denmark.
The primary endpoint of the study is symptoms of Post Traumatic Stress Disorder; the secondary endpoints
are depression and anxiety as well as quality of life, functional capacity, coping with pain, body awareness
and physical fitness.
Discussion: This study will examine the effect of physical activity for traumatised refugees. This has not yet
been done in a randomised controlled setting on such a large scale before. Hereby the study will contribute
to important knowledge that is expected to be used in future clinical guidelines and reference programs.
Trial registration: ClinicalTrials.gov NCT01955538. Date of registration: 18 September 2013.
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Background
The treatment of traumatised refugees comprises one of
the fields of psychiatry with the least scientific knowledge
[1, 2]. Thus, there is a serious lack of systematic research
on treatment outcomes in traumatised refugee populations,
and the lack of evidence motivated the present study.
By far the majority of studies of posttraumatic stress
disorder (PTSD) have focused on road victims, rape vic-
tims and war veterans. There is reason to believe that
the possibility of benefiting from treatment is related to
the range and nature of the trauma that underlies the
trauma-related disorder. Consequently, it is a problem
that the four existing Cochrane analyses on treatment
effect on PTSD among adults only include very few
studies based on refugee populations [1–4].
Evidence based treatment for this complex patient
group is therefore scarce. This leads to uncertainty con-
cerning the treatment which should be offered and po-
tentially lowers the quality of life of the patients [5].
The overall research question of this study is to
evaluate if adding physical activity to standard psychi-
atric treatment improves the mental health, quality of
life and functioning of traumatised refugees. Thereby,
the focus of this study is on the relationship between
physical activity and PTSD, including effects of phys-
ical activity on the comorbidities of PTSD, one of
which is chronic pain.
Chronic pain is a commonly seen co-morbidity to
PTSD [6–10]. According to the well-established "Mu-
tual Maintenance Theory", PTSD and chronic pain will
mutually maintain the symptoms of one another [8].
Consequently, treatment of chronic pain plays a cen-
tral role in improving the treatment and wellbeing of
patients with PTSD. Nevertheless, little scientific
knowledge exists on how to treat chronic pain in trau-
matised refugees.
Biological and psychological theories have hypothe-
sised on and clinical studies have examined the effects of
physical activity on other psychiatric illnesses than PTSD
[11–18], including some of the important co-morbidities
to PTSD. Regarding depression, a central comorbidity to
PTSD [19–24], the evidence is based on few methodic-
ally robust studies and systematic reviews which suggest
small or moderate effects of physical activity [21, 25, 26].
Importantly, positive effects of physical activity have also
been seen for chronic pain [27–35].
However, scientific knowledge about physical activity as
part of the treatment for traumatised refugees is very lim-
ited and no national or international guidelines exist on
this topic [2, 5, 36]. Despite this, physical activity in vari-
ous forms is often used as part of the treatment for trau-
matised refugees. Just as it is the case for depression, the
potential working mechanisms behind the effect of phys-
ical activity on symptoms of PTSD are unclear.
Only a few randomised controlled trials on trauma-
tised refugees with PTSD investigate physical activity as
the intervention. A small randomised controlled trial
published in 2011 on the influence of physical activity
on chronic pain and symptoms of PTSD based on the
"Mutual Maintenance Theory" [37], examined the effects
of mixed physical activities (exercises of stretching,
strength and endurance) as additive therapy to psychoe-
ducation and biofeedback-based cognitive behavioural
therapy. The study showed larger effect sizes for coping
with pain and for improvements in symptoms of anxiety
in the physically active group, suggesting specifically that
physical activity is a valuable addition to pain manage-
ment for traumatised refugees [37]. However, the study
is small (n = 30) and these preliminary results need repli-
cation in a larger trial [37].
Basic Body Awareness Therapy (BBAT) is one type of
physical activity, which has been studied as intervention in
a number of trials on other illnesses such as chronic pain,
fibromyalgia, schizophrenia, personality disorders and non-
specific musculoskeletal disorders [14, 16, 29–31, 38].
BBAT is a modification of BAT (Body Awareness Therapy)
and was first described by the French psychoanalyst
and actor, J. Dropsy [39]. It focuses on the basic func-
tion of movements related to posture, coordination,
free breathing and awareness [29]. The aim of Basic
BAT is to integrate the body in the total experience of
the self and to restore body awareness and body control
[40]. As for the type of physical activity, BBAT is gentle
and non-strenuous; which is another reason why it
could be suitable for traumatised refugees.
In order to test the feasibility of BBAT on a group of
traumatised refugees, a pilot study was conducted in
2012 [41] at the Competence Centre for Transcultural
Psychiatry (CTP). In this pilot study, Arabic-speaking
patients were treated with weekly BBAT sessions in
groups, for a period of 13 weeks. Fourteen patients were
included and 9 patients (5 men and 4 women) com-
pleted the BBAT treatment. The study was primarily
qualitative and semi-structured interviews were con-
ducted with all patients. The participants showed high
acceptability, compliance and satisfaction with BBAT,
and this was also the case in a previous study on patients
with prolonged musculoskeletal disorders [42]. Some pa-
tients in the CTP pilot study chose not to participate
due to the group element.
The Cochrane review; ”Sports & Games for post-
traumatic stress disorder” from 2010 concludes: “Rando-
mised controlled trials assessing the effect of sport and
game interventions are needed to inform the current
practice of using sports and games to improve symptoms
of PTSD” [2]. This is in line with the results of more
recent above-mentioned studies and points to the fact
that there is a need for more systematic research examining
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a number of unsolved issues: 1) how effective is physical ac-
tivity as a treatment of symptoms of PTSD and of chronic
pain; 2) what are the relative benefits of different types of
physical activities; 3) whether group or individual physical
activity is the most efficient; 4) what is the optimum dur-
ation of physical activity; 5) what intensity does the physical
activity need to have in order to have an effect.
Objectives
The objectives of this study are 1) to examine the differ-
ences in treatment outcome of patients treated respect-
ively with or without physical activity as an add-on
treatment to psychiatric treatment as usual (TAU); 2) to
study if BBAT has a higher impact on the outcome mea-
sures compared to mixed physical activity; 3) to investi-
gate if an increase in physiological parameters such as
strength, endurance, balance and coordination correlates
with an improvement in mental health; 4) to examine if
the number of hours spent on home exercises with the
planned physical activity is a positive predictor of the
treatment effect.
Methods
This study is a parallel group superiority study with an
allocation ratio of 1:1:1. The study is a randomised con-
trolled trial and will include approximately 310 trauma-
tised refugees in the period from September 2013 to
September 2015. Of those patients a minimum of 200
are expected to complete the trial in accordance with
the protocol.
The trial setting is the Competence Centre for
Transcultural Psychiatry (CTP), at Mental Health
Centre Ballerup, situated in the Capital Region of
Denmark. All doctors, psychologists and physiotherap-
ist working on the project are working according to
manuals, and have been trained in the use of the
manuals. The manuals have been developed specific-
ally to the patient group of traumatised refugees. Re-
garding the physical activity, only physiotherapist
certified with BBAT competence are treating patients
with BBAT. For further and more detailed description
of CTP and its working methods, see the recently
published articles [43, 44].
Concerning adherence to the protocol (regardless if
it is a consultation with a doctor, psychologist or
physiotherapist), the methods or themes and exercises
used in each session are registered in the medical rec-
ord of the patient immediately after the treatment ses-
sion. Regular meetings with the physiotherapists are
being held to monitor and ensure quality of the
research-related treatment and data collection and
discuss manual related issues.
The patients are being randomised into three groups:
all three groups receive TAU (see the later section about
TAU). While one of the three groups is a control group
and solely receives TAU, the two other groups (both ac-
tive comparator groups) receive add-on treatment in the
form of physical activity. One of the groups is assigned
to Basic Body Awareness Therapy (BBAT) while the
other group is assigned to mixed physical activity (MPA)
(see the later section about the specific interventions).
For all three groups the treatment period is approxi-
mately 6–7 months.
In the study only the outcome assessors carrying out
the Hamilton Depression and Hamilton Anxiety rating
(Hamilton D + A) [45] are blinded. These outcome as-
sessors only know that the patients are in the study but
are not aware of the allocated treatment. Unblinding is
not necessary. In a potential emergency situation such as
severe suicidal thoughts during depression rating the re-
sponsible doctor or another medical doctor will be called
for without need for unblinding the Hamilton rater.
The outcome assessors carrying out the observer rated
Hamilton D + A are trained medical students and they
participate in regular training sessions to ensure high
interrater variability.
The assessment of the majority of outcomes takes
place three times during the treatment period where
the patients fill out self-administered rating scales: once
at the pre-treatment consultation (baseline), once
halfway through the treatment (before the first psycho-
therapy session) and once just after finalising the treat-
ment (see also Additional file 1 and Fig. 1). Furthermore
the medical doctor also fill out a rating scale (Global
Assessment of Functioning and Global Assessment of
Symptoms [46]) three times during the course of treat-
ment as well as HoNOS before and after the course of
treatment [47]. The ratings and tests specifically related to
the physical activity will take place independently from
the other ratings at the beginning and at the end of the
assigned intervention of physical activity. All ratings scales
and tests (physiotherapeutic as well as psychological) will
be performed and filled out by the patients in all three
treatment groups, regardless whether the patient is in one
of the active comparison groups or in the control group.
The blinded observer-ratings of depression and anxiety
are carried out at the start and at the end of the treatment
period. The applied rating scales are described in the out-
come section below.
The primary endpoint of the study will be symptoms of
PTSD, and secondary endpoints will be depression, anxiety,
and quality of life, functional capacity, coping with pain,
body awareness and physical fitness. For an illustration of
the course of the study, see Additional file 1 and Fig. 1.
If needed, an interpreter will be present at each con-
sultation during all parts of the intervention. The patient
will have one assigned interpreter that follows the pa-
tient during the entire course of treatment. Interpreters
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are being used for approximately 70 % of the consulta-
tions. All interpreters are used to working within the set-
ting of CTP where research and treatment are integrated
and they know the questionnaires and rating scales well.
An introduction meeting is held with the interpreters at
the start of the trial to ensure their understanding of the
research project and the methods used in the project.
Participants
The study aims at including 310 patients of which 200
are expected to complete the treatment (based on expe-
riences from the previous randomised trials carried out
at CTP). The inclusion period is planned to last for
approximately 2 years.
The patients included in the study are all adult (≥18
of age) traumatised refugees or traumatised persons
who have been family renunified with a refugee. Re-
garding the background/nationality of the patients, we
expect a representation which is relatively similar to
what has been shown in a recent study of the patients
at CTP [48]. This implies that the majority of patients
are expected to originate from the Middle East, with
the biggest proportion originating from Iraq followed by
Palestinians, Afghans and Iranians. Patients from Bosnia
and Serbia are also expected to be well-represented
[48]. Patients are referred to the clinic either by their
general practitioner or by a referring doctor in a spe-
cialist unit. If the patient is considered likely to be in
the target group for treatment at CTP, the patient is
invited for a pre-treatment assessment with a medical
doctor. The experience from the former randomised
clinical trials conducted at CTP tells that a high per-
centage of the patients are positive towards participating
in research projects and no special strategies are used
to achieve the adequate number of participants.
The participants are not receiving any provision or
compensation for participation in the study. However all
participants are subjected to “The rights of a trial subject
in a biomedical research project” by the Danish National
Committee on Biomedical Research Ethics [49].
Inclusion criteria
The inclusion criteria for the trial are the following: Pa-
tients must be referred to treatment for PTSD at CTP
from September 2013 to September 2015; age 18 or
older; must be refugees or persons who have been family
reunified with a refugee; have PTSD according to the
ICD-10 research criteria; psychological trauma in the
past; assessed by a medical doctor to be motivated for
treatment; provide written informed consent.
Exclusion criteria
Patients will be excluded from the trial if they have a se-
vere psychotic disorder (defined as patients with an
ICD-10 diagnosis F2x and F30.1-F30.9); are current
abusers of drugs or alcohol (F1x.24-F1x.26); are physic-
ally disabled in a way which prohibits participation in
the physical activities; have cardiac arrhythmia identified
Fig. 1 Course of treatment and data collection. The course of treatment consists of phase 1 and phase 2. Both self-administered ratings and
observer-ratings (blinded as well as well as non-blinded) will be applied in the study
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on the electrocardiogram taken before start of the treat-
ment or symptoms of heart problems that are unclarified.
Treatment groups
All three groups receive psychiatric treatment as usual
(TAU). The control group is assigned to TAU alone
(see the later section about TAU). The two other
groups are assigned to a combination of TAU and add-
on treatment consisting of either Basic Body Awareness
Therapy or mixed physical activity respectively. The
add-on treatment starts approximately 2 weeks after
the beginning of TAU and is provided individually.
The course of treatment and procedure for the ratings
are illustrated in Additional file 1 and Fig. 1. A detailed
description of the intervention is given below.
The intervention and the course of treatment in an
overview
The intervention consists of physiotherapeutic treat-
ment, in which the two active comparator groups
are being assigned to each type of physiotherapeutic
treatment as add-on treatment to the treatment as
usual (TAU).
Treatment as usual (TAU)
TAU overall consists of 6–7 months of medical treat-
ment according to best clinical practice in the field and
manual-based CBT.
TAU is divided into two phases and consists of the fol-
lowing two elements:
Consultations with a medical doctor
As part of TAU each patient is offered 10 consultations
with a medical doctor. During phase 1 (the first two
months), these consultations take place approximately
once a week and are primarily concerning medication
and psychoeducation. If indicated, the medical doctor
will as part of TAU initiate and monitor pharmaco-
logical treatment, and the psychoeducation includes a
wide range of topics such as symptoms of PTSD and
depression; the rationale of treatment; physical activity,
bodily reactions and anxiety; how PTSD affects the
brain; sleep disturbances; healthy life style, including a
proper diet and exercise; breathing and relaxation exer-
cises, and chronic pain. One-page hand-outs are avail-
able on all the topics in five different languages. The
hand-outs are given to the patient after having been
discussed during a consultation.
The psychoeducational treatment is thoroughly de-
scribed in the treatment manual followed by all doctors.
During the consultations, medication is initiated in ac-
cordance with the medical treatment algorithm of the
clinic, which constitutes the pharmaceutical part of
TAU. The algorithm is based on the present knowledge
on treatment of traumatised refugees [5, 50, 51]. In ac-
cordance with this, sertraline is first choice medication,
and venlafaxine second choice of medication. Further-
more mianserine in small doses can be added if the pa-
tient has sleep disturbances as a central problem.
Phase one is followed by phase two (the next four
months) where the consultation with the medical doctor
takes place once a month.
In case extra consultations are needed (e.g. when im-
portant psychosocial or medical problems arise) these
are noted in the patients´ medical record.
Psychotherapy by a psychologist
A psychologist carries out 16 sessions of approximately
1 hour in a treatment period of four months according
to the CBT manual. The manual has been made specif-
ically for this patient group and the methods, which are
being used, have been adapted to fit the patient group
[52]. All psychologists have all been trained in using
the manual.
Physiotherapeutic intervention
Regardless of the assigned physical activity, the partici-
pants will be scheduled to one weekly, individual session
for a total of 20 weeks. One session lasts approximately
1 hour. Every patient is assigned one regular physiother-
apist during the whole course of treatment. To ensure
consistency regarding the treatment both physiothera-
peutic interventions are manualised and the physiothera-
pists have been trained in using the manuals. Both
physiotherapeutic interventions have a method sheet
outlining the different topic/themes, which the physio-
therapy should cover (e.g. “strength”, “endurance”, “bal-
ance” etc. for Mixed Physical Activity, as well as “Body
Scan”, “Rotation”, “The Wave” etc. for Basic Body
Awareness) with a number of specific exercises con-
nected to every topic/theme. At the weekly session the
physiotherapist will register the attendance of each
patient, the exercises used during the session and the
patient’s individual degree of participation in each exer-
cise. Furthermore the amount of homework reported by
the patient will be registered. With regard to the inten-
sity of training, both physiotherapeutic interventions are
at their starting point mild forms of training suitable for
the patient group. Meanwhile, there is a certain flexibil-
ity to adapt the intensity to the physical capacity and/or
physical limitations of the individual patient.
All patients in all three intervention groups are tested
with objective physiotherapeutic assessment instruments
and tests as well as self-administered rating scales at the
beginning and end of the course of the physiotherapeu-
tic treatment (see the section about outcomes below).
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Basic body awareness therapy (BBAT)
BBAT is a body-oriented physiotherapeutic approach.
BBAT uses a perspective on physiotherapy treatment
directed towards an awareness of how the body is used,
in terms of body function, behaviour and interaction
with the self and others [53]. For more description of
BBAT, see also the description of BBAT in the section
“Background” above.
Only physiotherapist certified with BBAT competence
will carry out the teaching of BBAT.
Mixed physical activity (MPA)
Physiotherapists with experience in working with trau-
matised refugees assisted developing the manual for the
teaching in MPA. The activities include exercises cover-
ing themes of strength, endurance, balance and coordin-
ation. As described in the section above, the specific
exercises are described in the manual and the actual
exercises and level of participation performed in a ses-
sion will be noted in the record of the patient.
Home exercises
Regardless of the assigned physical activity the physio-
therapist will motivate the patients to do home exercises.
The home exercises will be specific exercises from the
type of physical activity that the patient is assigned to
and will be demonstrated in the training sessions. After
every session, the physiotherapist records the reported
homework in the patient medical chart.
Concomitant care
The participants will not be referred from CTP to other
physical activities during their participation in the trial.
If they at the beginning of the study are already in some
sort of physiotherapy/physical activity this is not discon-
tinued during the trial.
Discontinuation of the intervention
Discontinuation of the allocated intervention will take
place if the patient wishes to stop participation in the
physical exercise, if the patient cannot at all participate
in the given physical exercise because of e.g. severe pain
or if a physical illness is diagnosed during the trial where
physical exercise is contraindicated.
Outcomes
Both self-administered ratings and observer-ratings
(blinded as well as well as non-blinded) will be applied
in the study. For details about the specific time points of
the different outcomes, see Additional file 1.
The outcomes have been chosen based on perceived
clinical relevance and from the perspective of enabling
comparison of the results of the study with results from
other studies made on the same patient group. A number
of studies on traumatised refugees have applied many of
the same outcomes as the present study, such as HTQ,
([37, 44, 57, 54–58], GAF [44, 52, 56, 59], HSCL-25 [44, 56,
60], HAM D+A [44, 56, 61], Symptom Checklist-90 (SCL-
90) [44, 48, 56], HSCL-25 [37, 44, 48, 60, 62–64],
WHO-5 [44, 56, 61], SDS [44, 54], VAS [7, 44, 56, 61, 65],
and HoNOS [66]. The selected outcomes are considered
clinically relevant as they have been used in other trials
on the same patient group or patients who are similar in
important aspects, e.g. pain-measures used for patients
with chronic non-malignant pain.
All outcome measures are scored on quantitative
scales, and interventions effects and group differences
can consequently be analysed as differences in means in
linear statistical models. Depending on the results it may
be relevant to analyse proportions with significant im-
provement using logistic regression..
The rating scales are all translated and available in five
different languages (Danish, Arabic, English, Bosnian/
Serbo-Croatian and Farsi), covering the mother tongue
of more than 80 % of our patients. If a version on the
mother tongue of a patient is unavailable, a translator
provides a verbal translation from the language that the
translator feels most familiar with.
Regarding harm outcomes, all serious adverse events
happening during the trial, whether caused by the inter-
vention or not, will consistently be registered and re-
ported to The National Committee on Health Research
Ethics.
Primary outcome measure
The primary outcome of the study is PTSD severity as
measured by by The Harvard Trauma Questionnaire
(HTQ) [57]. HTQ is a self-administered rating scale
assessing the severity of PTSD symptoms. It is inter-
nationally applied [67] and thoroughly validated in sev-
eral different languages and adapted for refugee
populations [58–60, 68, 69]. The first 16 questions of
the HTQ, Part IV (symptoms part) are used to monitor
PTSD symptoms. These 16 questions cover all PTSD
criteria in accordance with ICD-10 as well as DSM-IV.
Secondary outcome measures
Hopkins Symptom Check List (HSCL-25) is a self-
administered rating scale assessing the severity of anx-
iety and depression symptoms [70]. It is internationally
applied and thoroughly validated [60, 70–74]. This is a
short version of the Symptom Checklist-90 (SCL-90) and
consists of 25 questions, 10 regarding anxiety and 15 re-
garding depression. In addition to this, the somatisation
part of SCL-90 is used.
The WHO-5 is a self-administered questionnaire
evaluating quality of life, and it consists of five questions
[75]. The questionnaire has been used to assess the
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quality of life in a number of psychiatric diagnostic
groups [75–79].
Sheehan Disability Scale (SDS) is a self-administered
rating scale measuring functional impairment with re-
gard to family, work and social network using three
visual analogue scales [80]. Evaluation of the scale has
shown that it is sensitive to treatment effects in psychi-
atric patients [81, 82].
Global Assessment of Functioning for symptoms (GAF-S)
and for functioning (GAF-F) are numeric observer rating
scales used to assess the degree of social and physical
functioning in adults [46]. The scales are widely used in
the field of psychiatry. They have been validated in many
languages and are used frequently in clinical studies in
the field [48, 83, 84]. They have been applied in studies
on PTSD in a number of patient groups [85, 86] also on
populations of traumatised refugees [44, 59].
Hamilton depression and anxiety scales (HAM-D and
HAM-A) are observer rating scales assessing depression
and anxiety on the basis of semi-structured interviews
[45]. The HAM-D and HAM-A ratings have been used
for psychiatric research [23, 82, 87] and assessment of
symptoms in torture survivors [56, 63]. They do not
require translation as they are based on interviews car-
ried out by the clinician.
HoNOS is an observer rating scale used to measure
the health and social functioning of people with severe
mental illness [88], and has also been used in a clinical
study on a population of traumatised refugees [47].
Pain on Visual Analogue Scale (VAS) is a self-
administered rating scale, assessing pain intensity in
the head, back, upper extremities and lower extrem-
ities with visual analogue scales [89].
Brief Pain Inventory (BPI) short form is a self-report
instrument assessing different aspects of pain [90]. It is
psychometric and linguistically validated on more than
20 languages [91].
Multidimensional Assessment of Interoceptive Aware-
ness (MAIA) is a self-report instrument, assessing intero-
ceptive body awareness [70].
Three objective physiotherapeutic instruments asses-
sing function are being used: Dynamic Gait Index (DGI)
to evaluate the dynamic/functional balance [92]; Senior
Fitness Test (SFT) assessing body strength and aerobic
fitness [93]; and De Morton Mobility Index (DEMMI),
assessing the mobility of patients with many physical
limitations [94].
Randomisation and data collection
Randomisation
All patients will be enrolled and randomised by the med-
ical doctor after a two-hour referral interview in accord-
ance with inclusion and exclusion criteria, including
giving an informed, written consent to the medical doctor.
At the referral interview and before randomisation, the
medical doctor will determine and place the patient in the
right stratification group (by gender and level of severity
of PTSD symptoms: score < or > 3.2 on the HTQ) and
later assign the patient to the intervention.
The randomisation sequence was computer generated
by the Department of Biostatistics at the University of
Copenhagen. This department is not otherwise involved
in the research project. Allocation is concealed by using
sealed, sequentially numbered envelopes. Two secretar-
ies not linked to the daily work at CTP manage the en-
velopes and they are also physically separated from CTP.
When a patient has been included in the study, the med-
ical doctor calls the secretaries administering the random-
isation envelopes, and medical doctor receives immediate
information on the allocated group, which is noted in the
record of the patient.
Data collection, management, and analysis
Sample size and power calculations
The inclusion for the trial will be terminated on September
30 2015. This is when a total of approximately 310 patients
have been invited in the trial. On the basis of the comple-
tion rate in previous similar randomised trials at CTP [10],
the estimated drop-out rate is about 25–30 %. At the
beginning of the trial the plan was to invite 250 pa-
tients, but due to a higher (30–35 %) drop-out rate than
expected (25–30 %), it was decided to invite approxi-
mately 310 patients. A conservative estimation of ex-
pected completers is set to 200.
If 200 patients are divided into three groups of about
65 patients, power to detect a group difference corre-
sponding to ½ SD will be 81 %, while power to detect a
difference of 1 SD will be close to 100 %. Differences in
quantitative outcomes less than ½ SD between the two
treatments are considered to be less relevant from a
clinical point of view.
Cut-off scores are available for several rating scales,
and these can be used to define categorical outcome
variables. If for example the proportions below cut-off
for clinical case status are 50 % and 25 % in two
groups, power will be close to 80 % to detect a signifi-
cant group differences.
Data collection methods
Data will be collected from self-administered ques-
tionnaires as well as observer rated rating scales. All
assessors have been trained in using the relevant rat-
ing scales. All collected data will be entered via double
data entry.
For patients who discontinue or deviate from interven-
tion protocols the following outcome data will be avail-
able at baseline: sex, age, information on, in- and
exclusion criteria and outcomes from the following
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ratings: HTQ-score, HSCL-25, GAF-F and GAF-S, SDS,
WHO-5, VAS.
Statistical analysis
Statistical analyses will be conducted in Stata 14. It is ex-
pected that pre-treatment scores will be available for more
patients than post-treatment scores. To conduct intention-
to-treat analyses with all patients, Full Information
Maximum Likelihood (FIML) will be used in analyses,
which include the post-treatment scores as outcome and
the pre-treatment scores as covariate. Stata’s structural
equation modeling procedure “sem” will be used to conduct
these analyses which incorporate all available information
including pre-treatment scores for patients without post-
treatment scores. The primary and secondary quantitative
outcome variables will be analysed in several models: 1)
Linear regression analyses of pre-treatment scores includ-
ing only indicator variables for the three groups; 2) Linear
regression of post-treatment scores in models including
only indicator variables for the three groups; and (3) FIML
with procedure sem to analyze post-treatment scores in
models including indicator variables for the three groups’
pre-treatment scores as predictors. For each analysis the
significance of differences between the groups will be evalu-
ated comparing the two intervention groups and each inter-
vention group with the group receiving TAU only. Due to
the randomisation the three groups are not expected to dif-
fer on pre-treatment scores but if regression analyses of the
pre-treatment scores shows significant group differences,
FIML analyses corresponding to step (3) above but includ-
ing variables with pre-treatment group differences in the
model will be used.
In addition to intention-to-treat analyses completer
analyses will be conducted according to the same strat-
egy described above. The non-adherence group is de-
fined as patients not following the protocol, e.g. because
of few attended treatment sessions. The per protocol
population is defined as those attending ≥ 10 physiother-
apy treatment sessions.
Cohen’s d will be used as effect size measure derived
from the baseline standard deviation. For the primary
HTQ outcome the SD is expected to be about 0.5 (on a
1–4 point scale), and thus a group mean differences of
0.25 will correspond to ½ SD.
Depending on the results of the linear analyses, cut-
offs can be used on symptom scores and logistic regres-
sion analyses can be carried out with over/under cut-off
as binary outcome.
A fully specified statistical analysis plan will be written
before unmasking.
The final report will follow the main CONSORT
guideline as well as its extension to non-pharmaceutical
interventions.
The non-adherence group is defined as patients not
following the protocol, e.g. because of a bigger number
of non-attended treatment sessions, admission to a psy-
chiatric hospital for longer periods/(more than a few
nights) during their participation in the trial. The per
protocol population is defined as those attending ≥ 10
physiotherapy sessions.
The multiplicity coming from two active arms and a
control group will be addressed by making a specific
comparison between the groups (as described in the
statistical analysis plan).
Potential attrition bias will be sought prevented by only
including patients motivated for treatment. Potential attri-
tion bias will be treated by making drop-out analysis and
intention-to-treat analysis.
Monitoring
A data monitoring team independent of the funder and
with no competing interests is monitoring the collected
data and ensuring that data are being collected as
planned according to protocol Furthermore, the unit of
Good Clinical Practice (GCP) is performing an external
monitoring of the trial and the data collection approxi-
mately every 2–3 months, although not mandatory for a
non-pharmaceutical trial. An External Audit by GCP has
also been performed on the trial, the process being inde-
pendent from investigator, sponsor and funder.
No interim analysis or stopping guidelines have been
made prior to the study.
The leadership of CTP is overseeing the trial. An




The Ethics Committee of the Capital Region of
Denmark and the Danish Data Protection Agency have
approved the trial protocol. The project recognises the
Declaration of Helsinki II. Participation in the study is
voluntary and requires informed, written consent. Par-
ticipants will be informed about the trial verbally and
in writing. Patients can stop treatment and leave the
trial at any time and taking part in the trial is not a pre-
requisite for receiving treatment at the clinic. Random-
isation is considered ethical, as current knowledge in
this field is so scarce that randomised controlled effect
studies in this area are needed. This implies that results
of the study are expected to improve treatment for
future patients and to stimulate to further research
within a relatively short time.
Furthermore, the trial is expected to generate a socio-
economic gain, as it seeks to improve treatment, thereby
creating better results for the patients regarding mental
health and quality of life as well as social functioning.
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This will not only help the patients but secondarily also
affect their families. No serious disadvantages or serious
adverse events are expected in any of the groups during
the trial.
Personal information about potential and enrolled pa-
tients is kept in the respective record of the patient in a
record room, locked behind two doors outside of normal
work hours. Deleting the patient identification list,
which combines the Civil Personal Registration (CPR)
number with the patient-ID when the permission for
data processing expires, will anonymise data. The proce-
dures for how to handle patient information, both dur-
ing and after the trial, have been approved by The
Danish Data Protection Agency. MN, JC, EL and LL will
gain access to the final dataset.
Protocol amendments
The methods described in this protocol reflect the current
protocol (v 3.0 dated July 12 2013). A summary of proto-
col amendments is summarised in Additional file 2.
All protocol versions and amendments have been sub-
mitted to the Ethics Committee of the Capital Region of
Denmark. Important changes in the protocol are also
reflected in the information material sent to patients
about the trial as well as on: www.clinicaltrials.gov.
Publications and dissemination
Positive as well as inconclusive or negative results will
be published.
After completion of data analysis, three publications
are planned regarding the following aspects of the study:
 The effect of physical activity as an add-on treatment
to psychiatric treatment as usual for traumatised
refugees.
 The mental health benefits of body awareness when
treating traumatised refugees with physical activity.
 The mental health benefits of improvement of
fitness parameters when treating traumatised
refugees with PTSD.
Trial results are planned to be disseminated on na-
tional as well as international conferences and meetings
for healthcare professionals as well as information meet-
ings with public participation. Furthermore results are
planned to be disseminated via public information chan-
nels such as e.g. information meetings, radio, newspa-
pers, magazines etc.
Trial results will also be communicated to the partici-
pants via a letter sent by post.
The Vancouver rules for authorship will be followed.
There will be no use of professional writers.
Public access to the protocol is not planned but indi-
viduals who are interested can address MN and gain ac-
cess to the protocol.
This study protocol is written following the SPIRIT ad-
vice (see Additional file 3).
Discussion
This study will examine the effect of physical activity for
traumatised refugees specifically in relation to effects on
mental health and on pain. This has not yet been done
in a randomised controlled setting on such a large scale
before. Hereby the study will contribute with important
knowledge that is expected to be relevant for publishing
in international journals and the results are expected to
be used in future clinical guidelines and reference pro-
grams for the patient group. Through this we expect the
study to have an impact of the quality and scope of fu-
ture treatment for traumatised refugees.
Trial status
Inclusion of patients for this trial has started September
13th 2013 and is expected to continue inclusion until
September 30 2015 (see also Additional file 4 for "WHO
Trial Registration Data Set" and Additional file 5 for "Pa-
tient information and consent form").
Endnotes
1Trial Sponsor: Jessica Carlsson, jessica.carlsson@regio
nh.dk. Competence Centre for Transcultural Psychiatry,
Mental Health Centre BallerupMaglevænget 2, 2750
BallerupDenmark
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